148 related articles for article (PubMed ID: 36258021)
21. Expression analysis of genes encoding
Boroujeni PB; Sabbaghian M; Totonchi M; Sodeifi N; Sarkardeh H; Samadian A; Sadighi-Gilani MA; Gourabi H
JBRA Assist Reprod; 2018 Sep; 22(3):185-192. PubMed ID: 29932616
[TBL] [Abstract][Full Text] [Related]
22. Long non‑coding RNA MLK7‑AS1 promotes proliferation in human colorectal cancer via downregulation of p21 expression.
Zhang R; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Zhao X
Mol Med Rep; 2019 Feb; 19(2):1210-1221. PubMed ID: 30535460
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
Zhong X; Lü M; Wan J; Zhou T; Qin B
Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
[TBL] [Abstract][Full Text] [Related]
24. CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis.
Zhuang K; Zhang J; Xiong M; Wang X; Luo X; Han L; Meng Y; Zhang Y; Liao W; Liu S
Cell Death Dis; 2016 Oct; 7(10):e2415. PubMed ID: 27735944
[TBL] [Abstract][Full Text] [Related]
25. The microRNA-381(miR-381)/Spindlin1(SPIN1) axis contributes to cell proliferation and invasion of colorectal cancer cells by regulating the Wnt/β-catenin pathway.
Zhou L; Wang H; Fang Z; Zhong M; He Y; Zou J; Huang S; Li J; Xiang X; Fang Z
Bioengineered; 2021 Dec; 12(2):12036-12048. PubMed ID: 34753384
[TBL] [Abstract][Full Text] [Related]
26. Hsa_circ_0014717 is downregulated in colorectal cancer and inhibits tumor growth by promoting p16 expression.
Wang F; Wang J; Cao X; Xu L; Chen L
Biomed Pharmacother; 2018 Feb; 98():775-782. PubMed ID: 29571246
[TBL] [Abstract][Full Text] [Related]
27. CDC5L Promotes hTERT Expression and Colorectal Tumor Growth.
Li J; Zhang N; Zhang R; Sun L; Yu W; Guo W; Gao Y; Li M; Liu W; Liang P; Deng W; Cui X
Cell Physiol Biochem; 2017; 41(6):2475-2488. PubMed ID: 28472785
[TBL] [Abstract][Full Text] [Related]
28. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways.
Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z
J Exp Clin Cancer Res; 2020 May; 39(1):76. PubMed ID: 32370786
[TBL] [Abstract][Full Text] [Related]
30. N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21.
Zhang S; Yu C; Yang X; Hong H; Lu J; Hu W; Hao X; Li S; Aikemu B; Yang G; He Z; Zhang L; Xue P; Cai Z; Ma J; Zang L; Feng B; Yuan F; Sun J; Zheng M
J Exp Clin Cancer Res; 2019 Dec; 38(1):490. PubMed ID: 31831018
[TBL] [Abstract][Full Text] [Related]
31. TEX11 modulates germ cell proliferation by competing with estrogen receptor β for the binding to HPIP.
Yu YH; Siao FP; Hsu LC; Yen PH
Mol Endocrinol; 2012 Apr; 26(4):630-42. PubMed ID: 22383461
[TBL] [Abstract][Full Text] [Related]
32. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S
Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366
[TBL] [Abstract][Full Text] [Related]
33. LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR-203b-3p activity and facilitating BCL2L1 expression.
Yang Z; An Y; Wang N; Dong X; Kang H
J Cell Physiol; 2020 Oct; 235(10):7449-7464. PubMed ID: 32064615
[TBL] [Abstract][Full Text] [Related]
34. The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity.
Di Y; Jing X; Hu K; Wen X; Ye L; Zhang X; Qin J; Ye J; Lin R; Wang Z; He W
Drug Resist Updat; 2023 Jan; 66():100909. PubMed ID: 36525936
[TBL] [Abstract][Full Text] [Related]
35. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer.
Liang XH; Li LL; Wu GG; Xie YC; Zhang GX; Chen W; Yang HF; Liu QL; Li WH; He WG; Huang YN; Zeng XC
BMC Cancer; 2013 Sep; 13():412. PubMed ID: 24006921
[TBL] [Abstract][Full Text] [Related]
37. An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A).
Fu Q; Du Y; Yang C; Zhang D; Zhang N; Liu X; Cho WC; Yang Y
Expert Opin Ther Targets; 2016 Jul; 20(7):771-82. PubMed ID: 27167185
[TBL] [Abstract][Full Text] [Related]
38. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
[TBL] [Abstract][Full Text] [Related]
39. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer.
Wang J; Yu S; Cui L; Wang W; Li J; Wang K; Lao X
BMC Cancer; 2015 Mar; 15():90. PubMed ID: 25884313
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-362 Inhibits Cell Proliferation and Invasion by Directly Targeting SIX1 in Colorectal Cancer.
Wan J; Yang J; Qiao C; Sun X; Di A; Zhang L; Wang D; Zhao G
Yonsei Med J; 2019 May; 60(5):414-422. PubMed ID: 31016902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
